Learn how to report adverse drug events to FDA MedWatch. This guide covers who can report, step-by-step submission methods, and tips for effective pharmacovigilance.
Biosimilars require special safety monitoring because they’re not identical to reference biologics. Learn how adverse event tracking works, why product identification matters, and what’s being done to improve global surveillance systems.